Published 1 day ago • loading... • Updated 1 day ago
Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific ...
Summary by Hastings Tribune
2 Articles
2 Articles
Reposted by
Hastings Tribune
Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific ...
Presentations at AHA to highlight Lexeo's cardiovascular gene therapy pipeline, including preclinical programs in desmoplakin and TNNI3 cardiomyopathies
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center2Last Updated100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium







